|
FAM173A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.616000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.977300E-03 |
| Normal-vs-Stage2 |
9.060800E-01 |
| Normal-vs-Stage3 |
2.942200E-01 |
| Normal-vs-Stage4 |
9.765000E-01 |
| Stage1-vs-Stage2 |
1.175810E-01 |
| Stage1-vs-Stage3 |
1.835440E-01 |
| Stage1-vs-Stage4 |
2.141900E-02 |
| Stage2-vs-Stage3 |
4.552000E-01 |
| Stage2-vs-Stage4 |
9.256000E-01 |
| Stage3-vs-Stage4 |
3.561000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.235530E-02 |
| Normal-vs-AfricanAmerican |
3.470500E-02 |
| Normal-vs-Asian |
9.887200E-01 |
| Caucasian-vs-AfricanAmerican |
5.783700E-04 |
| Caucasian-vs-Asian |
5.413800E-01 |
| AfricanAmerican-vs-Asian |
4.035000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.594300E-02 |
| Normal-vs-Female |
4.857600E-01 |
| Male-vs-Female |
1.453990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.534800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.235700E-02 |
| Normal-vs-Age(61-80Yrs) |
6.337900E-02 |
| Normal-vs-Age(81-100Yrs) |
5.621000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.449800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.105800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.803800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.894400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.578440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.306830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.755810E-01 |
| Normal-vs-Grade 2 |
1.496120E-03 |
| Normal-vs-Grade 3 |
6.960600E-01 |
| Normal-vs-Grade 4 |
8.655400E-01 |
| Grade 1-vs-Grade 2 |
7.153600E-01 |
| Grade 1-vs-Grade 3 |
2.344400E-01 |
| Grade 1-vs-Grade 4 |
1.140030E-01 |
| Grade 2-vs-Grade 3 |
6.896500E-03 |
| Grade 2-vs-Grade 4 |
7.235900E-03 |
| Grade 3-vs-Grade 4 |
6.241400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.81370000002157E-06 |
| Normal-vs-ccB subtype |
6.374400E-02 |
| ccA subtype-vs-ccB subtype |
9.803700E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.314970E-01 |
| Normal-vs-N1 |
9.241600E-01 |
| N0-vs-N1 |
5.278800E-01 |
|
|
